by Mollie McDowell | Mar 2, 2015 | Rock Weekly
March 2, 2015 We’re (obviously) over the moon about the growing popularity of digital health—but unintended consequences grow alongside innovation. For one, as the line between patient and consumer gets blurred, so do the regulatory roles of the FDA and theFTC. And...
by Mollie McDowell | Feb 23, 2015 | Rock Weekly
February 23, 2015 Last week the FDA gave our friends at 23andMe a big green light to market genetic testing for one specific disease—and announced plans to re-classify similar tests moving forward. If the FDA is affecting your mental health, we have a...
by Mollie McDowell | Feb 16, 2015 | Rock Weekly
February 16, 2015 A huge chunk of the 125% growth in digital health funding has flowed to companies embracing new healthcare reform-fueled business models. From telemedicine to consumer engagement and HITECH to HealthKit, become an expert with our series about how...
by Mollie McDowell | Feb 9, 2015 | Rock Weekly
February 9, 2015 “Every smart tech person I know is working in healthcare,” said legendary investor John Doerr at our CEO Summit last week. Healthcare is hot—and clearly so is (stealing) health data, helped by the fact that the industry’s cybersecurity lags far...
by Mollie McDowell | Feb 2, 2015 | Rock Weekly
February 2, 2015 POTUS praised EMRs, wearables, and data for their impact on the future of medicine, and called on entrepreneurs (and investors) to create tools for patients as part of the newly-unveiled Precision Medicine Initiative. Needless to say, sharing genetic...
by Mollie McDowell | Jan 26, 2015 | Rock Weekly
January 26, 2015 While digital health may be lagging on the public market, conversations about the industry dominated Inside the Beltway last week. POTUS kicked everything off by announcing the Precision Medicine Initiative (more on what it needs to actually...
Recent Comments